Funding news
NovAccel Inc. logo

NovAccel Inc. Raises $1.2

Recently funded · $1.2B SeedHospitals and Health CareJPView source

Get the full NovAccel Inc. company profile

Access contacts, investors, buying signals & more

Open in Dashboard

NovAccel Inc., a company aiming to secure the supply of critical medical radioisotopes for advanced cancer treatments, has successfully closed a $1.2B Seed funding round. The substantial capital injection will fuel its mission to leverage proprietary superconducting accelerator technology for the manufacture of medical RIs like Actinium-225.

This particular radioisotope is indispensable for Targeted Alpha Therapy, an emerging next-generation cancer treatment, highlighting the strategic importance of NovAccel's work in the healthcare sector. The early-stage capital underscores the urgent demand for stable production of these vital materials.

Other Japan companies recently funded

View all

Biggest recent Healthcare rounds

Largest funding rounds in Healthcare on Signalbase right now.

#CompanyAmount
1
Kismet logo

Kismet

Australia

$42.0B
2
Johnson & Johnson logo

Johnson & Johnson

United States

$7.0B
3
Inari Medical logo

Inari Medical

United States

$4.9B
4
MultiPlan logo

MultiPlan

United States

$4.5B
5
BABYLON HEALTHCARE SERVICES LIMITED logo

BABYLON HEALTHCARE SERVICES LIMITED

United Kingdom

$4.2B

Other recent Seed rounds

Companies that recently closed a Seed round.

#CompanyAmount
1
Dessn logo

Dessn

United Kingdom

$6.0M
2
Crunchyroll logo

Crunchyroll

United States

$750.0K
3
RSA Cross Border logo

RSA Cross Border

$1.5M
4
Highwood Emissions Management logo

Highwood Emissions Management

Canada

$3.0M
5
Preveta logo

Preveta

United States

$2.0M